Related Experiment Video
Updated: Jun 27, 2026
13:04
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
Methodological comparisons for benefit-risk assessment in complex decision-making: applications and insights from a
Jian-Yu E1, Kexin Zhu2, Stéphanie Tcherny-Lessenot3
1Epidemiology and Benefit-Risk, Sanofi, Cambridge, MA, United States.
Frontiers in Drug Safety and Regulation
|June 26, 2026
Summary
Comparing eight benefit-risk assessment (BRA) methodologies, this study found that combining descriptive and quantitative frameworks offers a comprehensive approach. This integration effectively addresses multiple criteria, stakeholder preferences, and uncertainties in healthcare decision-making.
Area of Science:
- Pharmacoeconomics and Health Technology Assessment
- Clinical Trial Analysis
- Regulatory Science
Background:
- Benefit-risk assessment (BRA) is complex, involving the integration of benefits, risks, and their perceived importance by stakeholders.
- Evaluating and comparing different BRA methodologies is crucial for informed decision-making in healthcare.
Purpose of the Study:
- To compare eight distinct benefit-risk assessment methodologies.
- To evaluate these methodologies using a case study approach, focusing on rimonabant.
Main Methods:
- Utilized data from European Public Assessment Reports, randomized controlled trials, and published literature.
- Assessed two descriptive frameworks, two quantitative frameworks, and four metrics/estimation techniques.
Main Results:
- Descriptive frameworks offer systematic structuring and criteria assessment but lack quantitative elements and stakeholder weighting.
- Quantitative frameworks integrate objective data with subjective preferences, calculating utility scores or acceptability indexes.
- Metrics provide straightforward numerical comparisons of individual benefit and risk criteria.
Conclusions:
- A comprehensive BRA necessitates a combination of descriptive and quantitative frameworks.
- Integrating these approaches accommodates multiple criteria, stakeholder preferences, and uncertainties effectively.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:14Decision Making: Traditional Method
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
01:09Decision Making: P-value Method
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:20Decision Making
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
Automatic decision-making is fast, intuitive, and relies on gut feelings...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...